Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
The European Journal of Neuroscience|January 29, 2011
Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null backgroundKavita Prasad, Elizabeth Tarasewicz, Pamela A Ohman Strickland, et al.The Journal of Pharmacology and Experimental Therapeutics|August 27, 2010
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in ratsAgnieszka Nikiforuk, Piotr Popik, Karla U Drescher, et al.NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.Journal of Parkinson'S Disease|February 3, 2020
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 CohortsShalini Padmanabhan, Thomas A Lanz, Donal Gorman, et al.Biorxiv : the Preprint Server for Biology|July 10, 2026
No evidence for direct physical interaction of 5-HT 2A -mGluR2 receptors in vitro or in vivoBlake A Fordyce, Yi-Ting Chiu, Nicholas J Wright, et al.JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.Annals of Clinical and Translational Neurology|September 5, 2020
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patientsRoy N Alcalay, Pavlina Wolf, Ming Sum Ruby Chiang, et al.NPJ Parkinson'S Disease|April 4, 2023
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson's diseaseSara Gomes, Alicia Garrido, Francesca Tonelli, et al.Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.Science Translational Medicine|July 15, 2026
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's diseaseAarash Bordbar, Bernard Bloem, Colton Lloyd, et al.Pageof 5